TrademarkDir
THE MOLECULAR LOGISTICS COMPANY
LIVE

Serial Number

98351754

Owner

Ride Therapeutics, Inc.

Attorney

Devon E. White

Filing Date

Jan 10, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

THE MOLECULAR LOGISTICS COMPANY Trademark

Serial Number: 98351754 • Registration: 7756538

THE MOLECULAR LOGISTICS COMPANY is a trademark filed by Ride Therapeutics, Inc. on January 10, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Ride Therapeutics, Inc. (3 trademarks)

One Mifflin Place
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

January 10, 2024

Registration Date

April 8, 2025

Goods & Services

Medical and scientific research services; Research and development of drug delivery platforms; Research and development in the field of technology and micro- and nano-engineering, namely, development of drug delivery agents for use in pharmaceutical and biomedical industry; Development of new technology for others for enabling the engineering and modification of mRNA and genes for the purpose of developing molecular and cellular drug delivery agents for use in pharmaceutical and biomedical industry

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Apr 8, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Mar 14, 2025 CNTA
EXAMINER'S AMENDMENT ENTERED
Mar 14, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 14, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 14, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 14, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2025 TEME
USE AMENDMENT ACCEPTED
Mar 13, 2025 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Feb 20, 2025 AUPC
USE AMENDMENT FILED
Feb 20, 2025 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2025 CRFA
TEAS AMENDMENT OF USE RECEIVED
Feb 19, 2025 EAAU
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 6, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 6, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2024 NWOS
NEW APPLICATION ENTERED
Jan 11, 2024 NWAP

Related Trademarks

More from this Owner

RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY

RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY

RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY

RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY

RIDE THERAPEUTICS

RIDE THERAPEUTICS

RIDE THERAPEUTICS

RIDE THERAPEUTICS